Skip to main content

Nemluvio 30 mg lyophilized powder for injection (dual-chamber prefilled pen contains powder and diluent) Images

Generic Name: nemolizumab

This medication has been identified as Nemluvio 30 mg lyophilized powder for injection (dual-chamber prefilled pen contains powder and diluent). It is supplied by Galderma Laboratories, L.P.

Nemluvio is used in the treatment of Prurigo Nodularis; Atopic Dermatitis and belongs to the drug class interleukin inhibitors. Nemluvio 30 mg lyophilized powder for injection (dual-chamber prefilled pen contains powder and diluent) is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Nemluvio 30 mg lyophilized powder for injection (dual-chamber prefilled pen contains powder and diluent) medicine

Nemluvio

Generic Name
nemolizumab
Strength
30 mg lyophilized powder for injection (dual-chamber prefilled pen contains powder and diluent)
Availability
Prescription only
Drug Class
Interleukin inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
Galderma Laboratories, L.P.
National Drug Code (NDC)
00299-6220

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.